News
Great news for the American people!” Just talked with Pfizer CEO and @SecAzar on our drug pricing blueprint. Pfizer is rolling back price hikes, so American patients don’t pay more.
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president sent a letter pushing drug companies to slash prices.
The laws are designed to keep a check on drug prices, and one expert told Barron’s a ruling in Pfizer's favor “would be a major earthquake” for the industry.
Pharmaceutical giant Pfizer agreed to postpone some drug price increases one day after President Donald Trump slammed the company on Twitter, saying it should be “ashamed” of the decision. On ...
While Pfizer CEO Albert Bourla, Ph.D., said he couldn’t reveal many details, he noted that Pfizer is in “very active discussions” around most favored nation drug pricing.
Pfizer agreed to pay the federal government nearly $785 million after one of its subsidiaries failed to provide drug rebates to Medicaid for heartburn medication, according to the Department of ...
British regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record 89.4 million pounds ($112.7 million) Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 ...
Despite rolling back price increases earlier this year, Pfizer CEO Ian Read said the drugmaker will likely go back to "business as normal" for drug price hikes come January, according to MarketWatch.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results